Lixte Biotechnology Holdings Inc. - Rasio nilai perusahaan marang dodolan LIXT

Simbol resmi perusahaan lixte.com (LIXT)

Lixte Biotechnology is scaling combined oncology therapies through partnerships with global centers. This linear chart of the EV/Revenue ratio on GURU.Markets demonstrates business resilience, with the indicator standing at 0.00. The development of inhibitors for various tumors mitigates risks, although geopolitical tensions and sanctions are currently hindering reagent logistics and the execution of international clinical trials.

Lixte Biotechnology, Inc. (LIXT): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 06.07.2026

Lixte Biotechnology Holdings - rincian analitis lan metrik utama (LIXT)

Pambiji fundamental perusahaan:LIXT, lixte.com
Produk sing diprodhuksi Lixte Biotechnology Holdings Inc.

The EV/Sales metric determines the market value of a business relative to its revenue, excluding the impact of leverage to identify the net value of the generated cash flow. By analyzing the EV/Sales valuation chart on GURU.Markets, an investor can see the speculative value of Lixte Biotechnology (LIXT), which, at its current stage of R&D in oncotherapy, does not rely on commercial sales, turning the indicator into a reflection of expectations for future innovations.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CTXR|Multiplikator EV/Sales Cellectar Corp (CLRB)|Rasio nilai perusahaan marang pendapatan BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales